2023

1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

   Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

2. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

   Journal of Headache and Pain, Vol. 24, Núm. 1